GBP2 and metabolic dysfunction-associated steatotic liver disease: In the context of nonalcoholic fatty liver disease, GBP2 expression is significantly elevated compared to normal hepatic tissues and contributes to hepatic lipid accumulation through the PPARγ–CD36 axis.